Close Menu

Breaking News

With the EUAs, a sample collection kit from Everlywell and tests from Gravity Diagnostics and Assurance Scientific may be used without a prescription.

The company brought in $279.6 million in revenues for the full year, which exceeded the consensus Wall Street estimate.

Net loss for Q4 and the year included a $406.9 million in-process research and development expense related to the acquisitions of ReadCoor and Cartana.

For the three months ended Dec. 31, 2020, the firm posted $34.5 million in revenues, up from $29.7 million in 2019 and beating analysts' estimate of $31.9 million.

One of the ancient mammoths sequenced belongs to a previously unknown lineage that hybridized with woolly mammoths to give rise to Columbian mammoths.

The grant will fund an investigation into long noncoding RNA and the role it plays in differing prognoses between Black and white breast cancer patients.

The administration will expand COVID-19 testing for schools and underserved populations, increase manufacturing of testing supplies, and increase genomic sequencing.

Vikor has invested an undisclosed amount to help the startup commercialize a direct-to-consumer service that includes genomic risk testing and liquid biopsy cancer screening.

LifeLabs and Multiplex Genomics, a University of Guelph spinout, will work together to provide SARS-CoV-2 testing in Canada and track variants of the virus.

Using whole-genome sequence data for thousands of African American individuals, researchers teased out ancestry effects on polygenic risk of the conditions.

Propel Labs' Bigfoot Spectral Cell Sorter technology, as well as about 40 of its employees, will become part of Thermo Fisher's Biosciences business.

The same researchers previously found a different Neanderthal-origin haplotype increased COVID-19 risk, highlighting their complex influence on humans.

Under the non-exclusive deal, Natera will use matched tumor and normal exome sequencing data from Personalis to validate the design of its Signatera ctDNA assays.

The notice was issued due to the company's extended period of non-compliance with the minimum $2.5 million stockholder's equity requirement for continued listing.

All the tests are authorized for use by CLIA-certified labs, while Visby's test may also be performed in a point-of-care setting.

The financing round brings the total amount of funding for Micronoma, a developer of microbiome-based cancer detection technology, to $6.5 million.

Exact's planned acquisition of Ashion, a sequencing lab based in Arizona, builds on the company's licensing of the TARDIS liquid biopsy technology from TGen in January.

For the three months ended Jan. 31, the firm said revenues rose to $1.55 billion from $1.36 billion a year ago, beating analysts' average estimate of $1.44 billion.

The firm's stock price has dropped since the announcement that the agency would need additional information and it has paused test shipments.

ZeClinics said it will use the CRISPR-Cas9 technology to create various zebrafish knockout variants for use as disease models.

Using the BRAF-V600 tumor mutation as a marker, investigators identified pre-treatment and on-treatment ties between ctDNA and patient outcomes.

Binx Health said the initial distribution of its platform will be to settings certified to perform moderate- or high-complexity diagnostic tests under CLIA.

The researchers found that 18 percent of pediatric cancer patients tested with MSK-IMPACT harbored one or more inherited risk mutation.

BioIQ will offer Fulgent's next-generation sequencing-based coronavirus assay on its diagnostic testing platform.

The company reported revenues of $627.5 million, up from $599.9 million in Q4 2019, and beating the consensus Wall Street estimate of $602.0 million.

Pages

Politico reports that the NYPD DNA database has grown since it announced it would be removing profiles from it.

Forbes reports that a structural biology lab at Oxford University studying the coronavirus was hacked.

Science reports that a Dutch research funding agency is combating a ransomware attack.

In Science this week: set of 64 haplotype assemblies from 32 individuals, and more.